LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity
HotCopper editor Isaac McIntyre takes you through all the biggest sub-$1 movers on the ASX markets and across the HotCopper forums ⁠you should be watching in the new week, using the forum’s HotList tracking page.Hear from all the ASX-listed companies that were at the RIU R...
Market Cap $2.921M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| CYP | Cynata to Present at Euroz Hartleys Healthcare Forum | 04/02/25 | ||
| CYP | CYP Completes Patent Application related to CAR-T Therapy | PRICE SENSITIVE | 20/04/18 | |
| CYP | Cyanta to Present at ARM Investor Day | 12/04/18 | ||
| CYP | Further US Patent Granted for Cynata Cymerus Technology | PRICE SENSITIVE | 11/04/18 | |
| CYP | Cleansing Notice | 04/04/18 | ||
| CYP | Appendix 3B-Exercise of Options | 04/04/18 | ||
| CYP | Cleansing Notice | 28/03/18 | ||
| CYP | Appendix 3B-Exercise of Options | 28/03/18 | ||
| CYP | FDA Grants Orphan Drug Designation to Cyanta for CYP-001 | PRICE SENSITIVE | 28/03/18 | |
| CYP | Cleansing Notice | 13/03/18 | ||
| CYP | Appendix 3B-Exercise of Options | 13/03/18 | ||
| CYP | Updated Top 20 Shareholders | 13/03/18 | ||
| CYP | Shaw and Partners Updates Cynata Research Coverage | 12/03/18 | ||
| CYP | Cleansing Notice | 28/02/18 | ||
| CYP | Appendix 3B-Exercise of Options | 28/02/18 | ||
| CYP | Response to ASX Aware Query | PRICE SENSITIVE | 28/02/18 | |
| CYP | Appendix 4D & Half-Year Financial Statements | PRICE SENSITIVE | 27/02/18 | |
| CYP | Excellent Data from Final Preliminary Evaluation Period | PRICE SENSITIVE | 27/02/18 | |
| CYP | Trading Halt | PRICE SENSITIVE | 22/01/18 | |
| CYP Cynata to Present at Euroz Hartleys Healthcare Forum | |||
| 04/02/25 | |||
| CYP CYP Completes Patent Application related to CAR-T Therapy | |||
| 20/04/18 | PRICE SENSITIVE | ||
| CYP Cyanta to Present at ARM Investor Day | |||
| 12/04/18 | |||
| CYP Further US Patent Granted for Cynata Cymerus Technology | |||
| 11/04/18 | PRICE SENSITIVE | ||
| CYP Cleansing Notice | |||
| 04/04/18 | |||
| CYP Appendix 3B-Exercise of Options | |||
| 04/04/18 | |||
| CYP Cleansing Notice | |||
| 28/03/18 | |||
| CYP Appendix 3B-Exercise of Options | |||
| 28/03/18 | |||
| CYP FDA Grants Orphan Drug Designation to Cyanta for CYP-001 | |||
| 28/03/18 | PRICE SENSITIVE | ||
| CYP Cleansing Notice | |||
| 13/03/18 | |||
| CYP Appendix 3B-Exercise of Options | |||
| 13/03/18 | |||
| CYP Updated Top 20 Shareholders | |||
| 13/03/18 | |||
| CYP Shaw and Partners Updates Cynata Research Coverage | |||
| 12/03/18 | |||
| CYP Cleansing Notice | |||
| 28/02/18 | |||
| CYP Appendix 3B-Exercise of Options | |||
| 28/02/18 | |||
| CYP Response to ASX Aware Query | |||
| 28/02/18 | PRICE SENSITIVE | ||
| CYP Appendix 4D & Half-Year Financial Statements | |||
| 27/02/18 | PRICE SENSITIVE | ||
| CYP Excellent Data from Final Preliminary Evaluation Period | |||
| 27/02/18 | PRICE SENSITIVE | ||
| CYP Trading Halt | |||
| 22/01/18 | PRICE SENSITIVE | ||
